Olanzapine and Clozapine Most Significantly Increase Appetite
Olanzapine and clozapine are the antipsychotics most strongly associated with increased appetite, with olanzapine demonstrating that 77.4% of first-episode patients develop increased appetite during treatment, typically within the first 4 weeks. 1
Hierarchy of Appetite-Increasing Effects
The antipsychotics can be ranked by their propensity to increase appetite and cause weight gain:
Very High Risk:
- Clozapine - highest anticholinergic activity and requires concurrent metformin to attenuate weight gain 2
- Olanzapine - 77.4% of patients experience increased appetite, with mean onset at 20.3 days 1
High Risk:
Moderate Risk:
Low Risk:
- Aripiprazole
- Amisulpride
- Haloperidol
- Ziprasidone 3
Clinical Significance of Appetite Increase
The appetite increase directly drives metabolic complications: patients with increased appetite on olanzapine had 91.7% gain >7% body weight versus only 42.9% in those without appetite increase (p=0.004). 1
- Earlier onset of increased appetite correlates with greater subsequent weight gain 1
- 50% of patients with increased appetite develop dyslipidemia within 12 weeks 1
- Increased appetite effects are more pronounced in males on olanzapine compared to haloperidol 4
Guideline-Recommended Mitigation
When prescribing clozapine or olanzapine, metformin should be offered concomitantly to attenuate weight gain, starting at 500 mg daily and titrating to 1 g twice daily as tolerated. 2 This represents a proactive strategy rather than waiting for weight gain to occur.
Key Monitoring Requirements:
- Assess renal function before starting metformin (contraindicated in renal failure) 2
- Annual monitoring of HbA1c, liver function, renal function, and vitamin B12 2
- Use modified-release metformin preparations to minimize gastrointestinal side effects 2
Common Pitfall to Avoid
Do not assume lower doses will reduce appetite increase or weight gain - no evidence supports that lower antipsychotic doses are associated with lower weight gain. 4 The effect appears to be a class property rather than dose-dependent within therapeutic ranges.